查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1716772

醫療外骨骼市場：按組件、類型、技術、功能、結構和最終用途分類－2025-2030 年全球預測

Medical Exoskeleton Market by Component, Type, Technology, Functionality, Structure, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2024年醫療外骨骼市場價值將達到16.6億美元，2025年將達到18.7億美元，複合年成長率為12.78%，到2030年將達到34.2億美元。

主要市場統計數據
基準年2024年 16.6億美元
預計2025年 18.7億美元
預測年份 2030 34.2億美元
複合年成長率（%） 12.78%

醫療外骨骼正在改變現代醫學的格局，為行動不便的患者帶來新的希望並改善生活品質。這些先進的設備結合了尖端機器人技術、工程技術和數位整合技術，為復健、患者照護和日常活動提供了無與倫比的支援。醫療外骨骼的出現不僅代表著科技的進步；它代表著醫療保健向以病人為中心的根本轉變。隨著這些設備的有效性透過臨床應用變得越來越明顯，醫療保健提供者正在尋求綜合的方法將它們整合到標準護理實踐中。增強的功能和改善的患者治療效果使這些系統在更廣泛的醫療保健創新領域中佔據重要地位。

本執行摘要旨在闡明醫療外骨骼市場的各個方面，從突破性的技術進步到告知市場趨勢的策略性細分。透過探索新興趨勢、挑戰和機會，相關人員可以獲得實際的見解，了解這些變革性設備如何為患者照護樹立新的標竿。透過對市場促進因素、競爭動態和市場機會的詳細分析，以下章節為理解醫療外骨骼如何不僅徹底改變患者照護，而且還重新定義臨床、研究和商業應用的行業標準奠定了基礎。

改變醫療外骨骼市場

醫療外骨骼市場的演變是由再形成產業技術、經濟和監管格局的變革性變化所定義的。機器人和感測器技術的創新大大提高了這些系統的性能和功能，從而能夠提供更精確、更適應的患者支援。先進的致動器、微控制器和感測器整合到硬體框架中，並配備複雜的控制和監控軟體，正在加速從實驗設備到商業性可行解決方案的轉變。超越傳統模式，新的通訊協定和設計不斷湧現，以滿足不同患者群體的不同需求，促進整體的行動援助方法。

此外，永續設計原則和成本最佳化策略指南產品開發。隨著外骨骼技術的有效性在研究和臨床試驗中檢驗，市場正在湧入大量投資和夥伴關係。重新專注於創新設計不僅可以提高設備效能，而且為更靈活、更具成本效益的生產流程鋪平了道路。協作研究努力和多學科方法實現了硬體和軟體組件之間的動態相互作用，使得設備能夠根據不同護理環境中的特定治療、健身或操作需求進行客製化。在這種不斷變化的情況下，營運商和醫療保健決策者越來越意識到這種轉型轉變的重要性，這種轉變有望長期改善患者的治療效果、員工安全和業務效率。

揭示市場動態的關鍵細分洞察

詳細研究市場細分可以發現對於確定醫療外骨骼產業未來發展方向至關重要的焦點趨勢。市場已從多個維度進行了研究，包括硬體和軟體差異化因素。進一步分析硬體組件，包括致動器、微控制器和感測器，它們在確保精確運動和自適應性能方面發揮著至關重要的作用。同時，包括控制軟體和監控軟體在內的軟體部分提供了必要的介面，以便於即時調整和以用戶為中心的客製化。綜合考慮這些方面，可以全面了解支援這些設備發展的技術支柱。

透過區分被動外骨骼和動力外骨骼，分割策略得到進一步擴展。這種差異強調了能量吸收支撐和功能性主動運動輔助之間的平衡，從而滿足了廣泛用戶的需求。當考慮所使用的技術時，從電氣、液壓、機械和氣動系統的研究中獲得的見解揭示了廣泛的設計可能性。每種技術方法都針對各種應用的效能進行了最佳化，確保設備在穩定性、效率和可靠性方面不僅滿足而且超越傳統的期望。

此外，基於功能的全身、下半身和上半身外骨骼分割突出了專門的設計如何滿足不同的解剖或功能要求。透過結構組成分析，市場分為剛性外骨骼和軟性外骨骼，每種類別在耐用性和舒適性方面都有獨特的優勢。最後，來自老年護理機構、家庭護理環境、軍事和國防應用、研究機構和大學以及體育和健身環境等終端用途領域的見解揭示瞭如何客製化這些設備以適應各種操作場景。這種多方面的方法不僅凸顯了醫療外骨骼的多功能性，而且使產品開發與快速發展的市場的特定需求保持一致。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 更重視受傷後和手術後的康復
      • 人口老化和預期壽命延長需要高效的旅行和康復
      • 神經系統疾病和肌肉骨骼疾病盛行率不斷上升
    • 限制因素
      • 醫療外骨骼的生產開發成本高
    • 機會
      • 增加對穿戴式外骨骼系統開發的投資和資金
      • 生物醫學工程師與醫療保健專業人員進行早期療育治療新合作
    • 任務
      • 與嚴格的臨床試驗和全面的監管核准相關的擔憂
  • 市場區隔分析
    • 組件：軟體對於實現自適應運動控制演算法的重要性日益增加
    • 最終用途：擴大醫療外骨骼在老年護理機構的應用，以提高行動能力
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 醫療外骨骼市場（按組件）

  • 硬體
    • 致動器
    • 微控制器
    • 感應器
  • 軟體
    • 控制軟體
    • 監控軟體

第7章 醫療外骨骼市場（按類型）

  • 被動外骨骼
  • 動力外骨骼

8. 醫療外骨骼市場（依技術）

  • 電
  • 油壓
  • 機器
  • 氣壓

第9章 醫療外骨骼市場（依功能）

  • 全身外骨骼
  • 下肢外骨骼
  • 上身外骨骼

第 10 章 醫療外骨骼市場結構分析

  • 剛性外骨骼
  • 軟外骨骼

第 11 章 醫療外骨骼市場（依最終用途）

  • 養老設施
  • 居家照護環境
  • 軍事和國防
  • 科學研究機構和大學
  • 運動與健身

12.美洲醫療外骨骼市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

13. 亞太地區醫療外骨骼市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

14.歐洲、中東和非洲醫療外骨骼市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • B-Temia Inc.
  • Comau SpA
  • Cyberdyne Inc.
  • Ekso Bionics Holdings Inc.
  • ExoAtlet, LLC
  • Focal Meditech BV
  • Honda Motor Co. Ltd.
  • Hyundai Motor Company
  • Levitate Technologies
  • Lockheed Martin Corporation
  • Mitsubishi Heavy Industries, Ltd.
  • Myomo, Inc.
  • Ottobock SE & Co. KGaA
  • P&S Mechanics Co., Ltd.
  • Panasonic Holdings Corporation
  • Parker Hannifin Corporation
  • ReWalk Robotics Ltd.
  • Rex Bionics Corporation
  • Roam Robotics
  • Toyota Motor Corporation
  • Trexo Robotics, Inc.
  • Wandercraft SAS
  • Yaskawa Electric Corporation
Product Code: MRR-3E32260F820F

The Medical Exoskeleton Market was valued at USD 1.66 billion in 2024 and is projected to grow to USD 1.87 billion in 2025, with a CAGR of 12.78%, reaching USD 3.42 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.66 billion
Estimated Year [2025] USD 1.87 billion
Forecast Year [2030] USD 3.42 billion
CAGR (%) 12.78%

Medical exoskeletons are transforming the landscape of modern medicine, offering renewed hope and improved quality of life for patients grappling with mobility challenges. These advanced devices, which combine cutting-edge robotics, engineering, and digital integration, provide unparalleled support in rehabilitation, patient care, and everyday mobility. The emergence of medical exoskeletons is not merely a technological evolution; it represents a fundamental shift toward a more patient-centric approach in healthcare. As the efficacy of these devices becomes increasingly evident through clinical applications, healthcare providers are exploring comprehensive ways to integrate them into standard care practices. Enhanced functionality and improved patient outcomes have positioned these systems as a critical aspect of the broader healthcare innovation narrative.

This executive summary intends to elucidate the myriad facets of the medical exoskeleton market-from groundbreaking technological advancements to the strategic segmentation that informs market trends. By examining the emerging trends, challenges, and opportunities, stakeholders are provided with actionable insights into how these transformative devices are setting new benchmarks in patient care. Through an in-depth analysis of market drivers, competitive dynamics, and regional opportunities, the following sections lay the groundwork for understanding how medical exoskeletons are not only revolutionizing patient care but also redefining industry standards across clinical, research, and commercial applications.

Transformative Shifts in the Medical Exoskeleton Landscape

The evolution of the medical exoskeleton market is defined by transformative shifts that are reshaping the industry's technological, economic, and regulatory landscape. Innovations in robotics and sensor technology have dramatically increased the performance and capability of these systems, enabling more precise and adaptive patient support. The integration of advanced actuators, microcontrollers, and sensors within hardware frameworks, accompanied by sophisticated control and monitoring software, has accelerated the transition from experimental devices to commercially viable solutions. Moving beyond traditional models, new protocols and designs have emerged that address the diverse needs of varied patient populations, thereby promoting an inclusive approach to mobility assistance.

Furthermore, sustainable design principles and cost-optimization strategies now guide product development. As research and clinical trials validate the effectiveness of exoskeleton technology, the market is witnessing an influx of investments and partnerships. This renewed focus on innovative design not only enhances device performance but also paves the way for a more agile and cost-efficient production process. Collaborative research initiatives and interdisciplinary approaches have enabled a dynamic interplay between the hardware and software components, ensuring that devices can be tailored to specific therapeutic, fitness, or operational needs across different care settings. In this evolving scenario, operators and healthcare decision-makers are increasingly aware of the importance of these transformative shifts, which promise to yield long-term improvements in patient outcomes, workforce safety, and operational efficiency.

Key Segmentation Insights Illuminating Market Dynamics

An in-depth review of market segmentation reveals focused trends that are pivotal in defining the future trajectory of the medical exoskeleton industry. The market is studied across multiple dimensions that include the differentiating elements of hardware and software. The hardware component is analyzed further to encompass actuators, microcontrollers, and sensors, which play crucial roles in ensuring precise movement and adaptive performance. In tandem, the software segment, which includes control software and monitoring software, provides the necessary interface that facilitates real-time adjustments and user-centered customization. Observing these aspects together creates a comprehensive view of the technological backbone that supports the evolution of these devices.

The segmentation strategy extends further by distinguishing between passive and powered exoskeletons. This differentiation underscores the balance between energy-absorbing support and functionally active movement assistance, thereby catering to a broad spectrum of user needs. When considering the technology used, insights derived from studying the electric, hydraulic, mechanical, and pneumatic systems reveal a vast arena of design possibilities. Each technological approach is optimized for performance across various applications, ensuring that devices not only meet but exceed conventional expectations for stability, efficiency, and reliability.

Moreover, segmentation based on functionality-comprising full body, lower body, and upper body exoskeletons-highlights how specialized designs serve distinct anatomical or functional requirements. An analysis of the structural composition divides the market into rigid and soft exoskeletons, with each category offering inherent advantages in terms of durability and comfort, respectively. Finally, insights from end-use segmentations, which cover elderly care facilities, homecare settings, military and defense applications, research institutions and universities, and sports and fitness environments, illuminate how these devices can be tailored to serve varying operational contexts. This multifaceted approach not only underscores the versatility of medical exoskeletons but also aligns product development with the specific demands of a rapidly evolving market.

Based on Component, market is studied across Hardware and Software. The Hardware is further studied across Actuators, Microcontrollers, and Sensors. The Software is further studied across Control Software and Monitoring Software.

Based on Type, market is studied across Passive Exoskeletons and Powered Exoskeletons.

Based on Technology, market is studied across Electric, Hydraulic, Mechanical, and Pneumatic.

Based on Functionality, market is studied across Full Body Exoskeletons, Lower Body Exoskeletons, and Upper Body Exoskeletons.

Based on Structure, market is studied across Rigid Exoskeletons and Soft Exoskeletons.

Based on End-Use, market is studied across Elderly Care Facilities, Homecare Settings, Military & Defense, Research Institutions & Universities, and Sports & Fitness.

Key Regional Insights Defining Market Expansion

A comprehensive analysis of regional insights reveals that the Americas continue to serve as a hotbed for innovation and high adoption rates of medical exoskeleton technology, driven by advanced healthcare infrastructure and strong investment in research and development. In parallel, the region encompassing Europe, the Middle East, and Africa is emerging as a fertile ground for exploratory initiatives and cross-border collaborations, which propel market growth through an amalgamation of traditional healthcare values and modern technological strides. Meanwhile, the Asia-Pacific region is rapidly gaining prominence due to favorable government policies, a robust manufacturing ecosystem, and increasing consumer awareness. This entire regional mosaic exemplifies not only the diversity of adoption dynamics but also the critical role that geographic, economic, and socio-cultural factors play in shaping the growth trajectory of the industry.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights and Market Competitiveness

An evaluation of key players within the medical exoskeleton sector reveals an industry marked by dynamic competitiveness and robust innovation. Prominent companies have each contributed unique advancements that underscore their commitment to integrating high-grade materials, precision engineering, and groundbreaking technological solutions. Industry frontrunners such as B-Temia Inc. and Comau S.p.A. have established themselves through innovative engineering and collaborative research, setting a strong benchmark for product reliability and performance. Cyberdyne Inc. and Ekso Bionics Holdings Inc. further illustrate market leadership by integrating advanced software systems that blend seamlessly with hardware-driven functionalities, enhancing the overall value proposition.

International giants including ExoAtlet, LLC and Focal Meditech BV have consistently extended their technological expertise by investing in research and development to address emerging patient needs. Honda Motor Co. Ltd. and Hyundai Motor Company have leveraged their industrial prowess into advancing exoskeleton technology, positioning themselves strategically as drivers of the evolution from concept to clinical application. Other significant industry contributors such as Levitate Technologies and Lockheed Martin Corporation, along with key players like Mitsubishi Heavy Industries, Ltd. and Myomo, Inc., have expanded the competitive landscape by focusing on both market diversification and adoption-centric innovation.

Additionally, companies like Ottobock SE & Co. KGaA, P&S Mechanics Co., Ltd., Panasonic Holdings Corporation, and Parker Hannifin Corporation have garnered recognized accolades for their consistent performance and creative engineering approaches. ReWalk Robotics Ltd. and Rex Bionics Corporation exemplify the merging of clinical research and practical application, while Roam Robotics, Toyota Motor Corporation, Trexo Robotics, Inc., Wandercraft S.A.S., and Yaskawa Electric Corporation continue to deliver solutions that challenge conventional norms. Collectively, these insights depict a market in steep ascent, characterized by fierce competition, rapid technological advancement, and an unwavering focus on improving patient quality of life.

The report delves into recent significant developments in the Medical Exoskeleton Market, highlighting leading vendors and their innovative profiles. These include B-Temia Inc., Comau S.p.A., Cyberdyne Inc., Ekso Bionics Holdings Inc., ExoAtlet, LLC, Focal Meditech BV, Honda Motor Co. Ltd., Hyundai Motor Company, Levitate Technologies, Lockheed Martin Corporation, Mitsubishi Heavy Industries, Ltd., Myomo, Inc., Ottobock SE & Co. KGaA, P&S Mechanics Co., Ltd., Panasonic Holdings Corporation, Parker Hannifin Corporation, ReWalk Robotics Ltd., Rex Bionics Corporation, Roam Robotics, Toyota Motor Corporation, Trexo Robotics, Inc., Wandercraft S.A.S., and Yaskawa Electric Corporation. Actionable Recommendations for Steering Industry Success

For industry leaders looking to make a significant impact in the burgeoning field of medical exoskeletons, a proactive approach based on actionable recommendations is paramount. The first recommendation is to invest strategically in research and development initiatives that foster innovations tailored to clinical and operational demands. Leaders should also design strategic partnerships that enhance product capabilities and foster cross-disciplinary innovation, ensuring that both hardware and software components remain at the cutting edge. It is crucial to monitor market trends continuously and adapt business strategies to align with evolving regulatory and technological landscapes.

In addition, companies should consider targeting untapped market segments by diversifying product portfolios to address specialized applications-whether the focus lies on full body, lower body, or upper body solutions. Emphasis should be placed on developing products that resonate with key end-use areas such as elderly care facilities, homecare settings, military and defense operations, academic research institutions, and sports and fitness centers. The incorporation of state-of-the-art technologies-ranging from electric to hydraulic, mechanical, and pneumatic systems-will further enhance the competitive advantage by broadening the spectrum of customization and performance.

Industry leaders must also adopt agile manufacturing models and lean operational practices that not only reduce production costs but also facilitate rapid scalability in response to market demands. Collaborative engagements with academic and research institutions can serve as a catalyst for innovative breakthroughs, while active participation in policy formulation and industry standards setting ensures that companies stay ahead of regulatory curves. Embracing these recommendations can not only optimize operational efficiency but also fortify a company's position as a trusted and forward-thinking authority in the medical exoskeleton space.

Conclusion: Embracing the Future of Medical Exoskeleton Innovations

In summary, the medical exoskeleton market is witnessing an era of profound technological innovations and strategic realignments. The key findings of this analysis underscore how advancements in hardware and software integration are paving the way for more effective and adaptive mobility solutions. The segmentation insights reveal a robust market structure that accommodates specialized designs, diverse technological applications, and varying end-use scenarios. Moreover, regional dynamics indicate that while the Americas lead in innovation, other regions are rapidly emerging as key contributors to market growth. Insights into competitive strategies further reflect a vibrant ecosystem where companies are continuously pushing the boundaries of what is achievable within this space.

It is clear that the future of medical exoskeletons is not only promising but is poised to redefine standards in mobility assistance, patient rehabilitation, and overall healthcare delivery. The comprehensive analysis provided here reaffirms the critical importance of innovation, strategic planning, and targeted market diversification. As the market continues to evolve, stakeholders must remain vigilant and adaptive, leveraging both technological advancements and market opportunities to drive sustained growth and enhance patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased focus on post-injury and post-surgical rehabilitation
      • 5.1.1.2. Aging population and rising life expectancy necessitating efficient mobility and rehabilitation
      • 5.1.1.3. Increasing prevalence of neurological and musculoskeletal disorders
    • 5.1.2. Restraints
      • 5.1.2.1. High production and development costs of medical exoskeletons
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments and funding to develop wearable exoskeleton systems
      • 5.1.3.2. Emerging collaborations between biomedical engineers and healthcare professionals for early-stage intervention therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with robust clinical trials and comprehensive regulatory approvals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Growing significance of software for enabling adaptive movement control algorithms
    • 5.2.2. End-Use: Increasing adoption of medical exoskeleton in elderly care facilities to provide enhanced mobility
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Exoskeleton Market, by Component

  • 6.1. Introduction
  • 6.2. Hardware
    • 6.2.1. Actuators
    • 6.2.2. Microcontrollers
    • 6.2.3. Sensors
  • 6.3. Software
    • 6.3.1. Control Software
    • 6.3.2. Monitoring Software

7. Medical Exoskeleton Market, by Type

  • 7.1. Introduction
  • 7.2. Passive Exoskeletons
  • 7.3. Powered Exoskeletons

8. Medical Exoskeleton Market, by Technology

  • 8.1. Introduction
  • 8.2. Electric
  • 8.3. Hydraulic
  • 8.4. Mechanical
  • 8.5. Pneumatic

9. Medical Exoskeleton Market, by Functionality

  • 9.1. Introduction
  • 9.2. Full Body Exoskeletons
  • 9.3. Lower Body Exoskeletons
  • 9.4. Upper Body Exoskeletons

10. Medical Exoskeleton Market, by Structure

  • 10.1. Introduction
  • 10.2. Rigid Exoskeletons
  • 10.3. Soft Exoskeletons

11. Medical Exoskeleton Market, by End-Use

  • 11.1. Introduction
  • 11.2. Elderly Care Facilities
  • 11.3. Homecare Settings
  • 11.4. Military & Defense
  • 11.5. Research Institutions & Universities
  • 11.6. Sports & Fitness

12. Americas Medical Exoskeleton Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Medical Exoskeleton Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Medical Exoskeleton Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Wandercraft's clinical trial validates natural, hands-free walking restoration for spinal cord injury rehabilitation supporting market expansion
    • 15.3.2. Innophys launches its Muscle Suit in Singapore to boost worker safety and productivity across healthcare, caregiving, and industrial sectors
    • 15.3.3. IIT Kanpur's launch of groundbreaking BCI-based robotic hand exoskeleton with closed-loop EEG control transforms stroke rehabilitation
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B-Temia Inc.
  • 2. Comau S.p.A.
  • 3. Cyberdyne Inc.
  • 4. Ekso Bionics Holdings Inc.
  • 5. ExoAtlet, LLC
  • 6. Focal Meditech BV
  • 7. Honda Motor Co. Ltd.
  • 8. Hyundai Motor Company
  • 9. Levitate Technologies
  • 10. Lockheed Martin Corporation
  • 11. Mitsubishi Heavy Industries, Ltd.
  • 12. Myomo, Inc.
  • 13. Ottobock SE & Co. KGaA
  • 14. P&S Mechanics Co., Ltd.
  • 15. Panasonic Holdings Corporation
  • 16. Parker Hannifin Corporation
  • 17. ReWalk Robotics Ltd.
  • 18. Rex Bionics Corporation
  • 19. Roam Robotics
  • 20. Toyota Motor Corporation
  • 21. Trexo Robotics, Inc.
  • 22. Wandercraft S.A.S.
  • 23. Yaskawa Electric Corporation

LIST OF FIGURES

  • FIGURE 1. MEDICAL EXOSKELETON MARKET MULTI-CURRENCY
  • FIGURE 2. MEDICAL EXOSKELETON MARKET MULTI-LANGUAGE
  • FIGURE 3. MEDICAL EXOSKELETON MARKET RESEARCH PROCESS
  • FIGURE 4. MEDICAL EXOSKELETON MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. MEDICAL EXOSKELETON MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. MEDICAL EXOSKELETON MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL EXOSKELETON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MEDICAL EXOSKELETON MARKET DYNAMICS
  • TABLE 7. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ACTUATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MICROCONTROLLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY CONTROL SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MONITORING SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY PASSIVE EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY POWERED EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ELECTRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HYDRAULIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY RIGID EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SOFT EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY ELDERLY CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTIONS & UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL EXOSKELETON MARKET SIZE, BY SPORTS & FITNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES MEDICAL EXOSKELETON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 202. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 210. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 218. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 226. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 234. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 242. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 250. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 258. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 266. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 274. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 282. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 283. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 290. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 291. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 298. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 299. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 306. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 314. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 322. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 323. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 324. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 330. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 331. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 332. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 333. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 338. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 340. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 346. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 347. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 348. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 349. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY STRUCTURE, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY MEDICAL EXOSKELETON MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 354. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 356. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES MEDICAL EXOSKELETON MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 360.